UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~December~~March 31, ~~2011~~2012

Emergent Health Corp.

(Exact name of registrant as specified in its charter)

Nevada

(State or other jurisdiction of incorporation or organization)

Commission File No. 000-54404 

208944630

(I.R.S. Employer Identification Number)

20104 VALLEY FORGE CIRCLE

KING OF PRUSSIA 19406

(Address of principal executive offices) (Zip Code)

866-427-6143

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

-1-

Emergent Health Corp.

Item 8.01 Other Events- ~~Analysis~~Management ofDiscussion ~~Fiscal~~and ~~Year 2011~~Analysis ~~Compared~~of toFirst ~~Fiscal~~Quarter ~~Year 2010,~~2012 ~~Balance~~Results ~~Sheet~~Compared ~~and~~to ~~Operating~~First ~~Statement~~Quarter ~~with Management Discussion~~2011

Emergent Health Corp. (the “"Company”") is a non -reporting public company performing a voluntary filing on this Current Report on Form 8-K (the “"Form 8-K”") to update the ~~historical unaudited financial statements and~~ Management Discussion and Analysis of Financial Condition and Results of Operations for the ~~fiscal~~first ~~year~~quarter of ~~2011~~2012 compared to the ~~fiscal~~first ~~year~~quarter of ~~2010~~2011 for its private and public investors.

For the ~~full~~first ~~year~~quarter of 2012, unaudited revenues for Jan. 1 to ~~Dec~~Mar. 31, ~~2011~~2012 ~~were~~are preliminarily estimated at approximately $~~710~~494,~~787~~509.1080 compared to $~~241~~70,~~830~~837.7161 for Jan. 1 to ~~Dec.~~March 31. ~~2010~~2011. This iswould be an ~~approximate~~up ~~290~~to 600% increase. The Company’'s sales for the ~~year~~first ~~2011~~quarter preliminarily seem to exceed ~~all~~the entire first half of last year by ~~over~~an estimated $~~450~~300,000.00. The Company attributes this to increased U.S.A. and International demand for multiple new products as well the successful launch of its new MultVitamin-MultiMineral with Stem Cell Nutrition and added Vitamin D. The Company is optimistic. However, there is no guarantee this volume or rate of increase will continue.

Net profit, (unaudited) before taxes for the period Jan. 1 to ~~Dec~~Mar. 31, ~~2011~~2012, appears preliminarily to be approximately up to $~~253~~189,~~442~~195.3917. This compares to $4830,~~292~~383.1633 for the period Jan 1, to ~~Dec~~Mar. 31, ~~2010~~2011. On a pretax per share basis this is $0.008 per share for the most recent quarter compared to $0.0013 per share to the comparable quarter last year. This is an approximate ~~500~~up to 600% increase and attributed to added sales plus tight cost control. These margins could decrease as there may be an ongoing need to further increase staff in the future and there is no guarantee these rates of increase will continue.

The Company’'s total assets as of ~~Dec~~Mar. 31, ~~2011~~2012 were preliminarily estimated at $1,~~056~~200,~~582~~000.7000 compared to $~~422~~ 435,~~177~~726.4700 as of ~~Dec~~Mar. 31. ~~2010.~~2011

The Company’'s cash position was preliminarily estimated at $1,~~025~~121,~~582~~002.7000 as of ~~Dec~~Mar. ~~301~~31, ~~2011~~2012 compared to $~~394~~405,~~481~~556.4700 as of ~~Dec~~Mar. 31, ~~2010~~2011.

The Company believes it is adequately funded for ~~the~~this ~~upcoming~~ year and moving forward. The Company expects to further introduce its Anti-Aging supplement this year, as well as other new products. Another 5000 bottle purchase of the Anti-Aging supplement bydid atake ~~third~~place ~~party~~as is anticipated last quarter. The Company continues to move forward on a beta networking launch that ~~could~~may make the Anti-Aging project more profitable than acting just as a vendor. The Company intends to retire a Convertible Preferred Stock outstanding to decrease potential dilution in the next quarter.

The ~~Exhibits~~above ~~below~~is intended as a “snapshot” overview. The term “preliminarily” is used as the Company is experiencing a Quick Books accounting integration issue. The Company is utilizing manually extracted correlations of cost accounting data from Quick Books, sales revenue figures from selling software and then performing actual bank statement comparisons. This leads to figures the Company believes are realistic estimates until the integration issue is resolved. Exhibits related to unaudited Balance Sheet and Operating Statement for ~~the~~2012 ~~2011~~ periods ~~indicated~~are intended at a later date after further review.

This voluntary filing contains certain "forward-looking" statements, defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. Statements, which are not historical facts, are forward-looking statements. The Company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors that could cause actual results to differ materially from those estimated by the Company.

-2-

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the ~~voluntary~~Registrant ~~filer~~ has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Emergent Health Corp.
Date: January 17, 2012	By:	/s/ John V. Cappello
Date: June 4, 2012	By:	/s/ John V. Cappello
		John V. Cappello
		CEO, Chief Financial Officer

-3-

Emergent Health Corp.

(A Development Stage Company )

King of Prussia, PA

Balance Sheet

December 31, 2011

Assets
Current Assets	$
Cash		1,025,582.70
Inventory		31,00.00
Total Assets		1,056,582.70
Liabilities and Stockholders’ Equity
Current Liabilities	$
Accounts Payable		55,605.90
Outstanding Checks		57,344.53
Total Current Liabilities		112,950.43
Long Term Liabilities ($200,000.00 Convertible Note) Total Liabilities Without Conversion		312,950.43
Stockholders’ Equity
Preferred stock, $.001 par; 20,000,000 shares authorized;20,000 shares issued and outstanding value		200.00
Common stock, $.001 par; 50,000,000 shares authorized; 23,000,000 issued and outstanding		23,000.00
Additional Paid in Capital With Addition of Limited Partners		550,000.00
Retained earnings during development stage		170,432.27
Total Liabilities and Stockholders’ Equity	$	1,056,582.70

Notes to Balance Sheet

A . Emergent Health Corp (the “Company”). changed its name from Rolling Stone Retirement Community, Inc. in May of 2007 and was formed on April 27, 2006 under the laws of the

State of Nevada.

B. Organizational costs represent management, consulting, legal, accounting and filing fees incurred to date in the formation of the company. Organization costs are expensed in accordance with Statement of Position 98-5, “Reporting on the Costs of Start-Up

Activities”.

C. All corporations formed under Nevada State Law, whether active or inactive, are subject to annual filing fees, but no franchise tax.

D. A corporate restructuring and stock split was done that had the net effect of increasing the total shares outstanding to 21,787,504 (about 18,500,000 restricted) in Dec., 2009. This compared to 19,806,101 shares outstanding in the prior year of 2008. The company had an account receivable in the amount of $240,000.00 which was collected in 2009.

E. The Company issued 250,000 shares of restricted shares in the first quarter of 2011 to the McCauley Law Firm as compensation for legal services. This increased total shares outstanding to 22,037,504.

F. On April 28, 2011, 962,496 shares were issued by the Company to its major shareholder for past services and pending patent licenses. This increased total outstanding shares to 23,000,000.

G. On May 24, 2011 the Company received $200,000.00 from an accredited investor in the form of a convertible note yielding 8% and convertible into 1,666,680 common shares at $0.12 per share

H. The Company added $200,000.00 in capital from the formation of a private limited partnership in 2011 carried on the books of the Company as General Partner available capital.

I. Accounts Payable and Checks Outstanding are best estimates at this time. Inventory has been rounded.

Prepared by John V. Cappello, C.F.O. Unaudited

-4-

Emergent Health Corp.

(A Development Stage Company)

King of Prussia, PA

Statement of Operations (1)

Period From Jan. 1, 2011 to Dec. 31, 2011

Revenues	$	706,941.77
Interest Income		3845.33
Total Revenue		710.787.10
Expenses
Total operating expenses		457,344.71
Net Profit for the Period Before Taxes		253,442.39
Net income per share based upon 23,000,000 Common shares issued and outstanding	$	0.011

1. Note to Statement of Operations

Allowance has not been made for federal or state income taxes. Inventory has not been fully cost accounted until sold. All information is subject to review by corporate accountant upon tax preparation.

Prepared By: John V. Cappello, CFO (Unauduted)

-5-

Filing Compare · Emergent Health Corp.